Follow the Spago Nanomedical AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Spago Nanomedical AB (publ) has recorded 17 reports. Market capitalisation: €93m. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: Peter Lindell. All data is accessible without an account.
17
Insider Decl.
n/a
Thresholds
€1m
17 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Buys €1mn/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
624,996 shares@ €0.00730.0052% mcap100.0% of flowBTA (betald tecknad aktie)ISINISIN SE0015530654FI:A003U076-1
17 of 17 declarations
About Spago Nanomedical AB (publ)
Spago Nanomedical AB (publ) is a Swedish company focused on developing targeted treatments for cancer. It is listed on the Stockholm Stock Exchange (XSTO).